ArticleFrontiers in oncology2022

Impact of the interval between neoadjuvant immunochemotherapy and surgery on surgical-pathological outcomes in non-small cell lung cancer.

Jiawei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.